Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tergus Pharma has announced a 100,000-square-foot building for its new headquarters and plans to invest to expand into commercial manufacturing.
read more
Phoenix Molecular Designs (PhoenixMD) has announced the completion of clinical trial supply manufacture for PMD-026.
read more
Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million investment last year.
read more
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
Thermo Fisher Scientific has announced a collaboration with Scinogy to develop and commercialize fit-for-purpose instrumentation and reagent systems.
read more
Quanterix announced the relocation of its headquarters to a brand new facility in Billerica, Mass.
read more
Devonian and Histapharm announced they have signed a binding LOI to negotiate the terms establishing Devonian as the exclusive site for manufacturing of Histapharm’s proprietary botanical drug.
read more
Brazil's National Health Surveillance Agency has qualified Axis Biotec manufacturing facility in Rio de Janeiro to register, import, manufacture and also store and distribute biologic drugs in Brazil.
read more
Lumos Diagnostics and RPS Diagnostics announced they have merged. The combined company will be called Lumos Diagnostics.
read more
Teva Pharmaceutical announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.
read more
Effective immediately, all Vetter sites in Germany will be supplied with only CO2 neutral energy from certified renewable energy sources.
read more
Macrogen has received GCLP (Good Clinical Laboratory Practice) accreditation from the Ministry of Food and Drug Safety (MFDS) in Korea.
read more
Particle Sciences has broadened its Drug Enforcement Administration (DEA) registration to become an authorized manufacturer of Schedule I substances.
read more
VAI has partnered with Adents to provide its pharmaceutical customers with a complete solution to meet upcoming requirements under the Drug Supply Chain Security Act (DSCSA).
read more
WuXi Biologics has entered into a strategic partnership LOI with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated facility and supply a commercial product for the global market.
read more